By Timothy Herr, Emergo Group
While we have reported on the one-year delay of Europe’s Medical Devices Regulation (MDR) due to the COVID-19 pandemic, we have not yet touched on the ramifications that this decision has on countries outside the European Union. The United Kingdom and the nations of the European Free Trade Association (EFTA) are affected due to their close economic and legal ties to the EU, but so are other countries that are working on aligning elements of their regulatory systems with the MDR or participating in data-sharing programs with the EU.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.